GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Becton, Dickinson and Co (NYSE:BDXB.PFD) » Definitions » Gross Margin %

BDXB.PFD (Becton, Dickinson and Co) Gross Margin % : 45.74% (As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Becton, Dickinson and Co Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Becton, Dickinson and Co's Gross Profit for the three months ended in Sep. 2024 was $2,487.00 Mil. Becton, Dickinson and Co's Revenue for the three months ended in Sep. 2024 was $5,437.00 Mil. Therefore, Becton, Dickinson and Co's Gross Margin % for the quarter that ended in Sep. 2024 was 45.74%.


The historical rank and industry rank for Becton, Dickinson and Co's Gross Margin % or its related term are showing as below:

BDXB.PFD' s Gross Margin % Range Over the Past 10 Years
Min: 42.17   Med: 45.35   Max: 49.33
Current: 45.22


During the past 13 years, the highest Gross Margin % of Becton, Dickinson and Co was 49.33%. The lowest was 42.17%. And the median was 45.35%.

BDXB.PFD's Gross Margin % is ranked worse than
61.49% of 805 companies
in the Medical Devices & Instruments industry
Industry Median: 51.89 vs BDXB.PFD: 45.22

Becton, Dickinson and Co had a gross margin of 45.74% for the quarter that ended in Sep. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Becton, Dickinson and Co was -0.90% per year.


Becton, Dickinson and Co Gross Margin % Historical Data

The historical data trend for Becton, Dickinson and Co's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Becton, Dickinson and Co Gross Margin % Chart

Becton, Dickinson and Co Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 42.29 45.12 44.92 42.17 45.22

Becton, Dickinson and Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33.44 43.07 45.67 46.23 45.74

Competitive Comparison of Becton, Dickinson and Co's Gross Margin %

For the Medical Instruments & Supplies subindustry, Becton, Dickinson and Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Becton, Dickinson and Co's Gross Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Becton, Dickinson and Co's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Becton, Dickinson and Co's Gross Margin % falls into.



Becton, Dickinson and Co Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Becton, Dickinson and Co's Gross Margin for the fiscal year that ended in Sep. 2024 is calculated as

Gross Margin % (A: Sep. 2024 )=Gross Profit (A: Sep. 2024 ) / Revenue (A: Sep. 2024 )
=9125 / 20178
=(Revenue - Cost of Goods Sold) / Revenue
=(20178 - 11053) / 20178
=45.22 %

Becton, Dickinson and Co's Gross Margin for the quarter that ended in Sep. 2024 is calculated as


Gross Margin % (Q: Sep. 2024 )=Gross Profit (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=2487 / 5437
=(Revenue - Cost of Goods Sold) / Revenue
=(5437 - 2950) / 5437
=45.74 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Becton, Dickinson and Co  (NYSE:BDXB.PFD) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Becton, Dickinson and Co had a gross margin of 45.74% for the quarter that ended in Sep. 2024 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Becton, Dickinson and Co Gross Margin % Related Terms

Thank you for viewing the detailed overview of Becton, Dickinson and Co's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Becton, Dickinson and Co Business Description

Address
1 Becton Drive, Franklin Lakes, NJ, USA, 07417-1880
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.